Sunday, 28 April 2024
  
Login

Australia's most trusted
source of pharma news

Sunday, 28 April 2024
Listen to this story 
News

New drug filings on the horizon

Posted 26 March 2024 AM

The TGA has handed out pathways for three innovative drugs, hinting at upcoming filings for Amgen, Norgine and Specialised Therapeutics.

Among the newcomers are two oncology candidates, including Amgen's potential first-in-class DLL3 bispecific T-cell engager therapy tarlatamab for small cell lung cancer (SCLC), which has been granted orphan status.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (27)

Clinical & Medical, R&D (11)

Regulatory, Pharmacovigilance & QA (7)

Devices (1)

Other (20)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.